< Back to situations

[PLACE]

Melanoma

Featured in 1 tracked story · first seen

Situations

[ACTIVE] [HEALTH] [ES] [US] [AL]

Moderna and Merck melanoma vaccine clinical trials

6 clusters · 359 sources · last updated

Latest: Moderna and Merck announce positive phase 3 results for mRNA melanoma therapy

Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (also known as V940 or mRNA-4157), an experimental personalized mRNA cancer vaccine. The therapy is designed to target